Delivery Order SPE2DB25D3306-SPE2DB25FUBGC

Award Date 4/3/25
Potential Completion Date 4/4/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product. The contract has a total ceiling value of $8,513.58 and runs through November 21, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product, with a total ceiling value of $8,045.51. The contract is a delivery order with a firm fixed price pricing type and a performance period ending on December 15, 2023. This award is part of a larger...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,040.22, is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 8, 2025 and is a firm fixed-price arrangement. This contract is part of a larger Indefinite Delivery Contract (IDC)...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product. The contract has a ceiling value of $5,900.84 and a period of performance through May 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $9,753.01, is for the delivery of Humulin R 500 Unit/mL Kwikpen 3mL, a diabetes medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication, with a ceiling value of $17,569.26 and a performance period through May 7, 2025. The contract is a delivery order, with a firm fixed price pricing type. It is not set aside for any particular business category. Amerisourcebergen Drug Corp is the prime contractor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,797.64 firm fixed-price delivery order is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a specialty pharmaceutical product. The contract has a completion date of September 26, 2023 and was awarded on September 25, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $8,330.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product, and has a completion date of June 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,863.44 delivery order contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product. The contract is not designated with a set-aside requirement, indicating it was awarded through open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,646.28 firm fixed-price delivery order is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has an ultimate completion date of May 15, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical,...
  • SPE2DB25D3306
    Indefinite Delivery Contract
  • SPE2DB25D3306-SPE2DB25FUBGC
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a specialty medication, with a ceiling value of $49,999.08 and a period of performance through April 4, 2025. This is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 7/6/25, 12:42 AM